Pankaj Jay Pasricha

Title: MD
Position: Vice Chair Department of Medicine
Organization: Johns Hopkins University School of Medicine
Country: USA

Dr. Pasricha received his training in gastroenterology at Johns Hopkins Hospital. In 1997 Dr. Pasricha assumed leadership of the GI Division at the University of Texas Medical Branch. In August 2007, Dr. Pasricha was appointed as Chief of Gastroenterology at Stanford University of Medicine, until assuming his current position back at Johns Hopkins in July 2012. Dr. Pasricha has served on the National Commission on Digestive Diseases, appointed by the Congress to provide a “roadmap” for progress in gastrointestinal disorders. He is also the founding Chair of the Center for Gastrointestinal Innovation and Technology, a body created by the AGA (American Gastroenterological Association). Dr. Pasricha served on the FDA GI Drug Advisory Committee for several years and continues to provide advice to the Agency on an ad hoc basis. Dr. Pasricha holds more than 50 patents issued by the USPTO and has co-founded several companies within both the medtech and biotech GI space including Apollo Endosurgery, Enterastim, First Aid Shot Therapeutics (FAST), Neurogastrx, Orphomed, Glyscend and others. He is a recipient of continuous federal funding for his research since 1995 and currently is the principal investigator on several NIH grants. His laboratory is interested in molecular mechanisms of visceral pain, gastrointestinal motility, the gut-brain axis, microbiota, neuromodulation and neural control of glycemic control and obesity. His clinical interests include GI motility disorders and abdominal pain as well as the development of novel endoscopic procedures and devices for a variety of gastrointestinal disorders. He has consistently been on Castle Connelly list America’s “Top Docs” as well as “Best Doctors”and has authored more than 300 manuscripts/book chapters. These diverse accomplishments reflect his interests, which span endoscopic, clinical and bench research as well as his passion to translate these discoveries for the benefit of patients.